首页|SMURF1泛素化调控OPRM1表达抑制软骨细胞损伤减轻骨关节炎的机制

SMURF1泛素化调控OPRM1表达抑制软骨细胞损伤减轻骨关节炎的机制

扫码查看
目的 探讨SMAD泛素化调节因子1(SMURF1)泛素化调控μ型阿片受体(OPRM1)表达对白细胞介素-1β(IL-1β)诱导的人软骨细胞损伤的作用及机制.方法 IL-1β诱导构建体外细胞模型,分组为:对照组(Control)、IL-1β诱导组(IL-1β)、空载体组(IL-1 β+oe/siNC)、过表达组(IL-1 β+oe-OPRM1)、低表达组(IL-1β+siSMURF1)、回复实验组(IL-1 β+siSMURF1+siOPRM1).实时荧光定量聚合酶链反应和免疫印迹实验检测OPRM1与SMURF1的mRNA和蛋白表达;细胞计数试剂盒(CCK-8)检测细胞活力;流式细胞术检测凋亡;试剂盒检测水平;ELISA试剂盒检测氧化应激和炎症水平.免疫沉淀、免疫共沉淀和放线菌酮实验检测相互作用关系.结果 IL-1β+siSMURF1 组细胞活力高于IL-1 β+siNC 组[(69.33±5.13)%比(38.33±5.86)%,t=6.89,P<0.05].IL-1 β+siSMURF1组凋亡率、氧化应激和炎症水平低于IL-1β+siNC组[(10.12±0.62)%比(15.28±1.16)%、(2.15±0.25)µm 比(4.24±0.12)μm、(2.63±0.11)μm 比(5.01±0.45)μm、(0.05±0.01)U/mg 比 0.12±0.01)U/mg、(88.68±5.13)pg/ml 比(135.33±10.21)pg/ml、(128.33±11.68)pg/ml 比(265.33±24.95)pg/ml,t=6.82、12.85、12.17、8.84、7.07、8.62,P<0.05],免疫沉淀、免疫共沉淀结果显示,siSMURF1组OPRM1泛素化水平高于siNC组(196.32±8.15 比 217.68±10.05,t=3.10,P<0.05).结论 SMURF1 通过泛素化调控 OPRM1的表达介导IL-1 β诱导的软骨细胞损伤以减轻骨关节炎.
The research on the mechanism of SMURF1 regulating OPRM1 expression through ubiquitination to inhibit chondrocyte damage and alleviate osteoarthritis
Objective Investigate the function and underlying mechanism of SMAD ubiquitination regulatory factor 1(SMURF1)in modulating the expression of µ-opioid receptor(OPRM1)via ubiquitina-tion,as well as its impact on chondrocyte damage in humans caused by interleukin-1 β(IL-1β).Methods The cells were divided into the following groups:Control group,IL-1[3-induced group(IL-1 β),empty vec-tor group(IL-1 β+oe/siNC),overexpression group(IL-1[3+oe-OPRM1),low expression group(IL-1 β+siSMURF1),and rescue experiment group(IL-1β+siSMURF1+siOPRM1).Real-time fluorescent quanti-tative PCR and immunoblotting experiments were conducted to detect the mRNA and protein expression lev-els of OPRM1 and SMURF1.MTT assays were used to assess cell viability.Flow cytometry was employed to detect apoptosis.The levels of oxidative stress and inflammation were detected by kits.Immunoprecipitati-on,co-immunoprecipitation,and cycloheximide chase experiments were performed to investigate the inter-action between OPRM1 and SMURF1.Result The cell viability in IL-1 β+siSMURF1 group was higher than that in IL-1 β+siNC group[(69.33±5.13)%vs.(38.33±5.86)%,t=6.89,P<0.05].The ap-optosis rate,oxidative stress and inflammation levels in IL-1 β+siSMURF1 group were lower than those in IL-1β+siNC group[(10.12±0.62)%vs.(15.28±1.16)%,(2.15±0.25)μm vs.(4.24±0.12)µm,(2.63±0.11)μm vs.(5.01±0.45)µm,(0.39+0.09)U/mg vs.(0.18+0.04)U/mg,(0.05±0.01)U/mg vs.(0.12±0.01)U/mg,(88.68±5.13)pg/ml vs.(135.33±10.21)pg/ml,(128.33±11.68)pg/ml vs.(265.33±24.95)pg/ml,t=6.82,12.85,12.17,8.84,7.07,8.62,P<0.05],The results of immunoprecipitation and co-immunoprecipitation showed that the level of OPRM1 ubiquitination in siSMURF1 group was higher than that in siNC group(196.32±8.15 vs.217.68±10.05,t=3.10,P<0.05).The results of cycloheximide experiment showed that the degradation rate of OPRM1 protein in siSMURF1 group was lower than that in siNC group at 6 h and 12 h(0.72±0.07 vs.0.47±0.10,0.64±0.06vs.0.25±0.035,t=3.71,9.85,P<0.05).Conclusion SMURF1 medi-ates IL-1 β-induced chondrocyte damage to alleviate osteoarthritis by regulating the expression of OPRM1 through ubiquitination.

OsteoarthritisUbiquitinationµ-Opioid receptorSMAD ubiquitination regula-tory factor 1Oxidative stress

骆晓飞、李哲、王金良、王少华、张昂克、王跃辉、魏瑄

展开 >

郑州市骨科医院健康城关节科,郑州 450052

郑州市骨科医院关节2科,郑州 450052

河南龙湖现代免疫实验室,郑州 451191

骨关节炎 泛素化 μ型阿片受体 SMAD泛素化调节因子1 氧化应激

2024

中华实验外科杂志
中华医学会

中华实验外科杂志

CSTPCD
影响因子:0.759
ISSN:1001-9030
年,卷(期):2024.41(12)